Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (51-60 of 401) with videos related to

Pageof 41
Sort By:
Thrombosis Research|January 26, 2005
Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirinRobert F Storey, Jane A May, Stan Heptinstall
Diabetes|November 21, 2022
Prolonged Inflammatory Response Post-Hypoglycemia: Mechanistic Insights Into the Relationship Between Low Glucose and Cardiovascular RiskAhmed Iqbal, Robert F Storey, Ramzi A Ajjan
The British Journal of Cardiology|November 18, 2024
Factor XI and XIa inhibition: a new approach to anticoagulant therapyMark Anthony Sammut, Nadir Elamin, Robert F Storey
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 10, 2019
Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?Mariusz Tomaniak, Robert F Storey, Patrick W Serruys
Seminars in Thrombosis and Hemostasis|March 7, 2017
Monitoring Antiplatelet TherapyRachel Orme, Heather M Judge, Robert F Storey
Platelets|December 19, 2002
Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart diseaseRobert F Storey, Robert G Wilcox, Stan Heptinstall
Journal of Thrombosis and Thrombolysis|May 22, 2021
International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic testsPaul A Gurbel, Udaya S Tantry, Robert F Storey
Expert Opinion on Drug Metabolism & Toxicology|October 5, 2023
Clinical pharmacology of selatogrel for self-administration by patients with suspected acute myocardial infarctionMartine Gehin, Robert F Storey, Corine Bernaud, et al.
Therapeutic Advances in Cardiovascular Disease|February 10, 2011
Antiplatelet therapy and vascular disease: an updateMamta H Buch, Bernard D Prendergast, Robert F Storey
International Journal of Cardiology|September 21, 2015
Dyspnea related to reversibly-binding P2Y12 inhibitors: A review of the pathophysiology, clinical presentation and diagnosticsMartin Unverdorben, Guido Parodi, Massimo Pistolesi, et al.
Pageof 41

Showing results (51-60 of 401) with videos related to

Sort By:
Pageof 41
Thrombosis Research|January 26, 2005
Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirinRobert F Storey, Jane A May, Stan Heptinstall
Diabetes|November 21, 2022
Prolonged Inflammatory Response Post-Hypoglycemia: Mechanistic Insights Into the Relationship Between Low Glucose and Cardiovascular RiskAhmed Iqbal, Robert F Storey, Ramzi A Ajjan
The British Journal of Cardiology|November 18, 2024
Factor XI and XIa inhibition: a new approach to anticoagulant therapyMark Anthony Sammut, Nadir Elamin, Robert F Storey
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 10, 2019
Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?Mariusz Tomaniak, Robert F Storey, Patrick W Serruys
Seminars in Thrombosis and Hemostasis|March 7, 2017
Monitoring Antiplatelet TherapyRachel Orme, Heather M Judge, Robert F Storey
Platelets|December 19, 2002
Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart diseaseRobert F Storey, Robert G Wilcox, Stan Heptinstall
Journal of Thrombosis and Thrombolysis|May 22, 2021
International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic testsPaul A Gurbel, Udaya S Tantry, Robert F Storey
Expert Opinion on Drug Metabolism & Toxicology|October 5, 2023
Clinical pharmacology of selatogrel for self-administration by patients with suspected acute myocardial infarctionMartine Gehin, Robert F Storey, Corine Bernaud, et al.
Therapeutic Advances in Cardiovascular Disease|February 10, 2011
Antiplatelet therapy and vascular disease: an updateMamta H Buch, Bernard D Prendergast, Robert F Storey
International Journal of Cardiology|September 21, 2015
Dyspnea related to reversibly-binding P2Y12 inhibitors: A review of the pathophysiology, clinical presentation and diagnosticsMartin Unverdorben, Guido Parodi, Massimo Pistolesi, et al.
Pageof 41